Phase I trial of anti-CS1 monoclonal antibody elotuzumab in combination with bortezomib in the treatment of relapsed/refractory multiple myeloma (Q34635516)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase I trial of anti-CS1 monoclonal antibody elotuzumab in combination with bortezomib in the treatment of relapsed/refractory multiple myeloma |
scientific article |
Statements
1 reference
Phase I trial of anti-CS1 monoclonal antibody elotuzumab in combination with bortezomib in the treatment of relapsed/refractory multiple myeloma (English)
1 reference
Kenneth C Anderson
1 reference
Paul G Richardson
1 reference
Daniel E H Afar
1 reference
Andrzej J Jakubowiak
1 reference
Don M Benson
1 reference
William Bensinger
1 reference
David S D Siegel
1 reference
Todd M Zimmerman
1 reference
Ann Mohrbacher
1 reference
Anil K Singhal
1 reference
30 January 2012
1 reference
1 reference
30
1 reference
16
1 reference
1960-1965
1 reference
Identifiers
1 reference
1 reference
1 reference